首页> 外文期刊>British journal of ophthalmology >Adal-1 bioadhesive for sutureless recession muscle surgery: a clinical trial.
【24h】

Adal-1 bioadhesive for sutureless recession muscle surgery: a clinical trial.

机译:Adal-1生物粘合剂用于无缝退缩性肌肉手术:一项临床试验。

获取原文
获取原文并翻译 | 示例
       

摘要

AIMS: To evaluate the efficacy and biotolerance of the Adal-1 adhesive for muscle sealing in strabismus surgery. METHODS: 27 eyes were included in the study: 17 in the control group and 10 in the study group. Surgery was performed on the recession of the horizontal rectus muscles. In the control group the muscle was joined to the sclera by a Vicryl 7/0 suture. In the study group, the Adal-1 adhesive was used instead. The efficacy of the sealing of the muscle to the sclera and the biotolerance of the surrounding tissues were evaluated. RESULTS: The muscular recession in the control group was 8.17 (SD 2.38) with displacement of the sealing point of 0.02 (1.7) mm. In the group sealed with adhesive, the muscular recession was 9.09 (3.08) and the displacement was 0.15 (1.56) mm, with no significant differences between the techniques (p<0.05). The inflammation of the surrounding tissues in the immediate postoperative period was greater with the suture technique (p>0.05), but there were no differences in the other postoperative periods (Mann-Whitney U test). CONCLUSION: Adal-1 was an effective and safe alternative to sutures in muscle recession for strabismus surgery in this study.
机译:目的:评估斜视手术中用于肌肉密封的Adal-1粘合剂的功效和生物耐受性。方法:27只眼被纳入研究:对照组17只,研究组10只。对水平直肌的后退进行手术。在对照组中,通过Vicryl 7/0缝合线将肌肉连接至巩膜。在研究组中,使用了Adal-1粘合剂。评估了肌肉对巩膜的密封效果以及周围组织的生物耐受性。结果:对照组的肌肉萎缩为8.17(SD 2.38),密封点的位移为0.02(1.7)mm。在用粘合剂密封的组中,肌肉后退为9.09(3.08),位移为0.15(1.56)mm,两种方法之间无显着差异(p <0.05)。术后立即用缝合技术对周围组织的炎症反应更大(p> 0.05),但在其他术后期间则无差异(Mann-Whitney U检验)。结论:在这项研究中,Adal-1是斜视手术中肌肉退缩缝合的有效替代方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号